欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2620/002
药品名称Zolmitriptan Nasal Medical Valley
活性成分
    • Zolmitriptan 5.0 mg/dose
剂型Nasal spray, solution
上市许可持有人Medical Valley Invest AB
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Rinovix
    • Germany (DE)
      Zolmitriptan Nasal AXiromed 5 mg/Dosis, Nasenspray, Lösung
    • Denmark (DK)
      Migrizol
    • Iceland (IS)
许可日期2025/09/03
最近更新日期2025/11/18
药物ATC编码
    • N02CC03 zolmitriptan
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase